Home >> Report Store >> Healthcare >> Fondaparinux Market Size, Share & Industry Report, 2025 >

Fondaparinux Market, By Types (Branded and Generic), By End Use (Clinics, Hospitals, Ambulatory Surgical Centres, Diagnostic Centres and Home Care Settings), By Geography (North America, Europe, Asia Pacific, and Rest of the World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

156 Pages | Published Date : June 2019 | Report Code: AV333 | Report Format: PDF

REPORT HIGHLIGHT

The fondaparinux market was valued at USD 388.9 million by 2017, growing with 6.4% CAGR during the forecast period, 2018-2025.

Market Dynamics

Fondaparinux is a molecule that is widely used in the pharmaceutical industry. This particular molecule is used as an anticoagulant (prevents the development of blood clots) in the healthcare industry. This drug due to its molecular structure as compared to regular heparin shows more efficacy. It is majorly used in medical conditions such as knee or hip replacement, deep vein thrombosis (DVT) and Pulmonary Embolism (PE). Arixtra, a type of Fondaparinux is the U.S. FDA approved drug to treat cases of pulmonary embolism especially in cases of DVT surgeries.

The benefits it offers over heparin is one of the reasons why this particular therapeutic has grown in this specific industry. One of the significant factors that will drive the market growth is the increase in the number of cases in knee and hip replacement. Since OECD Health Statistics 2017, stated that on an average the cases of hip replacement increased 30% from the year 2000 to 2015. Anticoagulants are also provided to geriatric populations due to a number of complications that could arise due to age-related diseases.

On contrary, there is a significant amount of uncertainty when it comes to government regulations regarding the use of fondaparinux, pull back the industry growth. Furthermore, this product is not very commonly promoted by doctors due to its associated side effects such as breathing issues, allergic reactions, numbness and muscle weakness.

Types Takeaway

The two major segments for this are generic and branded. Fondaparinux has a generic form of it available as an injectable blood thinner, popularly known as Arixtra. One of the most common End Uses for this product is the treatment for DVT and pulmonary thromboembolism. This product is quite highly priced, one of the major reasons for it is due to an extremely difficult manufacturing process the drug has to go through. It is a highly stringent and complex process. This is also a reason why fondaparinux is consumed with limitations.

To a great extent, an improvement in the R&D facilities can drastically change the way these products are manufactured. Governments across the globe are promoting the practice of using generic drugs from a regulatory standpoint. Countries such as France, Japan, and Spain have all adopted policies that promote the use of these generic drugs as there is better control over the pricing for these as compared to branded products. From an end use perspective generally the drug is used in hospitals, clinics, ambulances, home care set ups and diagnostic facilities across the healthcare set up.

Regional Takeaway

An increase in the number of increased diseases, tumors, cardiovascular diseases in North Americas one of the reasons why North America is one of the leading users of the drug Fondaparinux.  Illnesses such as haematological, neurological and CVD are increasingly predominant in North America. China is the second highest when it comes to consuming this product because the country is an evolving market from a pharmaceutical industry standpoint. It has been central when it comes to the manufacturing of various API’s from a global standpoint.

Key Vendor Takeaway

The key market players of this industry are GlaxoSmithKline Plc, Alchemia Ltd., Abbott Laboratories, Inc., Dr. Reddy’s Laboratories, Apotex, Inc., ScinoPharm Taiwan Ltd., Aurobindo Pharma and Lupin Pharmaceuticals. This is the consolidated industry, where handful companies capture significant revenue share.

Key players are engaged in new product introduction and merger and acquisitions to attract large customer base. For instance, in December 2017, Aurobindo Pharma received approval of Fondaparinux Sodium injection (5 mg/0.4 mL, 2.5 mg/0.5 mL, 10 mg/0.8 mL and 7.5 mg/0.6 mL single-dose prefilled syringes) from the US Food & Drug Administration (USFDA).

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year – 2014 & 2016
  • Base Year – 2017
  • Estimated Year – 2018
  • Projected Year – 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPE

  • Branded
  • Generic

MARKET, BY END USE

  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Home Care Settings
  • Clinics
  • Hospitals

MARKET, BY REGION

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

TABLE OF CONTENT

1. FONDAPARINUX MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by End Use
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. FONDAPARINUX KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. FONDAPARINUX INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. FONDAPARINUX MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. FONDAPARINUX MARKET – BY TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Type, 2017 & 2025 (%)
6.2. Branded
   6.2.1. Overview
   6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Generic
   6.3.1. Overview
   6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. FONDAPARINUX MARKET – BY END USE
7.1. Overview
7.1.1. Segment Share Analysis, By End Use, 2017 & 2025 (%)
7.2. Ambulatory Surgical Centres
   7.2.1. Overview
   7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Diagnostic centres
   7.3.1. Overview
   7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Home Care Settings
   7.4.1. Overview
   7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5. Clinics
   7.5.1. Overview
   7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.6. Hospitals
   7.6.1. Overview
   7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. FONDAPARINUX MARKET– BY GEOGRAPHY
8.1. Introduction
8.1.1. Segment Share Analysis, By Region, 2017 & 2025 (%)
8.2. North America
   8.2.1. Overview
   8.2.2. Key Manufacturers in North America
   8.2.3. North America Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
   8.2.4. North America Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
   8.2.5. North America Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.2.6. U.S.
   8.2.6.1. Overview
   8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.7. Canada
   8.2.7.1. Overview
   8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Europe
   8.3.1. Overview
   8.3.2. Key Manufacturers in Europe
   8.3.3. Europe Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
   8.3.4. Europe Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
   8.3.5. Europe Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.3.6. France
   8.3.6.1. Overview
   8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.7. Germany
   8.3.7.1. Overview
   8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.8. Rest of Europe
   8.3.8.1. Overview
   8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Asia Pacific (APAC)
   8.4.1. Overview
   8.4.2. Key Manufacturers in Asia Pacific
   8.4.3. Asia Pacific Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
   8.4.4. Asia Pacific Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
   8.4.5. Asia Pacific Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.4.6. China
   8.4.6.1. Overview
   8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.7. India
   8.4.7.1. Overview
   8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.8. Rest of APAC
   8.4.8.1. Overview
   8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5. Rest of the World
   8.5.1. Overview
   8.5.2. Key Manufacturers in Rest of the World
   8.5.3. Rest of the World Market Size and Forecast, By Country, 2014 – 2025 (US$ Million)
   8.5.4. Rest of the World Market Size and Forecast, By Type, 2014 – 2025 (US$ Million)
   8.5.5. Rest of the World Market Size and Forecast, By End Use, 2014 – 2025 (US$ Million)
8.5.6. Latin America
   8.5.6.1. Overview
   8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.7. Middle East and Africa
   8.5.7.1. Overview
   8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. GlaxoSmithKline Plc
   9.1.1. Company Snapshot
   9.1.2. Financial Performance
   9.1.3. Product Benchmarking
   9.1.4. Strategic Initiatives
9.2. Alchemia Ltd.
9.3. Abbott Laboratories, Inc.
9.4. Dr. Reddy’s Laboratories
9.5. Apotex, Inc.
9.6. ScinoPharm Taiwan Ltd.
9.7. Aurobindo Pharma
9.8. Lupin Pharmaceuticals
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us

List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Fondaparinux market: Type snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Type
TABLE Global Fondaparinux market, by Type 2014-2025 (USD Million)
TABLE Fondaparinux market: End Use snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by End Use
TABLE Global Fondaparinux market, by End Use 2014-2025 (USD Million)
TABLE Fondaparinux market: Regional Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Fondaparinux market, by Region 2014-2025 (USD Million)
TABLE North America Fondaparinux market, by Country, 2014-2025 (USD Million)
TABLE North America Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE North America Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE U.S. Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE U.S. Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Canada Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Canada Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Europe Fondaparinux market, by country, 2014-2025 (USD Million)
TABLE Europe Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Europe Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Germany Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Germany Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE U.K. Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE U.K. Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Rest of the Europe Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Rest of the Europe Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Asia Pacific Fondaparinux market, by country, 2014-2025 (USD Million)
TABLE Asia Pacific Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Asia Pacific Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Japan Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Japan Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE China Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE China Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Rest of Asia Pacific Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Rest of Asia Pacific Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Rest of the World Fondaparinux market, by country, 2014-2025 (USD Million)
TABLE Rest of the World Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Rest of the World Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Latin America Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Latin America Fondaparinux market, by End Use, 2014-2025 (USD Million)
TABLE Middle East and Africa Fondaparinux market, by Type, 2014-2025 (USD Million)
TABLE Middle East and Africa Fondaparinux market, by End Use, 2014-2025 (USD Million)

List of Figures
FIGURE Fondaparinux market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Type segment market share analysis, 2017 & 2025
FIGURE Type segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Braned market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Generics market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE End Use segment market share analysis, 2017 & 2025
FIGURE End Use segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Ambulatory surgical centres market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Diagnostic centres market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Home care settings market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Clinics market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Hospitals market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Regional segment market share analysis, 2017 & 2025
FIGURE Regional segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE North America Fondaparinux market share and leading players, 2018
FIGURE Europe Fondaparinux market share and leading players, 2018
FIGURE Asia Pacific Fondaparinux market share and leading players, 2018
FIGURE Latin America Fondaparinux market share and leading players, 2018
FIGURE Middle East and Africa Fondaparinux market share and leading players, 2018
FIGURE North America market share analysis by country, 2018
FIGURE U.S. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Canada market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Europe market share analysis by country, 2018
FIGURE U.K. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Germany market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of the Europe market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Asia Pacific market share analysis by country, 2018
FIGURE India market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE China market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of Asia Pacific market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Rest of the World market share analysis by country, 2018
FIGURE Latin America market size, forecast and trend analysis, 2014 to 2025 (USD Million)
FIGURE Middle East and Africa market size, forecast and trend analysis, 2014 to 2025 (USD Million)

SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including Technology launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments.

KEY BENEFITS OF THE REPORT
• The report presents macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• Thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new Technology developments

RESEARCH METHODOLOGY

Research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study includes extensive use of secondary sources, paid databases (such as Bloomberg, Dun & Bradstreet, and BusinessWeek) and directories, to identify and collect information, useful to understand technical, commercial and market-oriented aspects. Market data and information are also collected (but not limited to) from the secondary sources such as:

  • Official company’s website, financial and annual reporting
  • Government statistical data
  • Online publishing articles
  • Industry player’s investor presentations
  • Economic news articles
  • National and international trade associations
  • The financial, business, and mainstream press
  • Industry study groups and semiofficial sources
  • Informative channels related to the market topics

* Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary            information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with the Key Opinion Leaders (KoL’s), operating in the respective markets, through phone calls, emails, and web-based survey responses. This platform help us validate our data in terms of accuracy and gain insight into the current market and future expectations. Furthermore, the obtained information guide us to understand several facets of the market with respect to manufacturers and buyers’ perspectives.

In addition, to assign weights to all the relevant market dynamics and parameters and quantify their market impact for generating projected market growth rate, we used advanced machine learning algorithms in order to collate essential market data. The machine learning method utilizes algorithms such as regression, correlation, and decision tree, among others, to derive the desired output. This tool help us in deriving highly detailed forecasts, profound knowledge of product demand, and others.

These collected data points are carefully filtered, analyzed, compared, and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level, and global level.

Market Forecast :

Market forecast is primarily based on the year-on-year (YOY) growth rate. Data projection and future performance of each segment is analyzed based on the key aspects extracted from primary and secondary research results. Thus, data projection exhibits the assumption on how the market performs under microeconomic and macroeconomic parameters. Our market forecasting technique represents strategic conclusions which can play a crucial role for our client’s in making strategic marketing plans.

For forecasting, the following parameters were considered:

  • Market drivers and restraints along with their current and expected impacts
  • Technological scenario and expected developments
  • Trends in the consumer behaviors
  • End-user industry trends

We have assigned weights to above-mentioned parameters and quantified their market impacts using the weighted average analysis, to derive an expected market growth rate.

Market Analysis

Another integral part of our research study is that market data is accompanied by clear written analysis. We include detailed information on market segments in terms of market drivers, market restraints, and market opportunities. These offer insights on different channel dynamics, brand preference, incidence/prevalence data, consumption trend, and technology up-gradations.

We also include supporting data from relevant awareness campaigns, new introductions, regulatory norms, government initiatives, and an industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView?

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

We make your satisfaction a priority

Share This